Reduced expression of the ATP2A2 gene in vemurafenib-induced keratoacanthoma-like papules in a melanoma patient

Int J Dermatol. 2017 Feb;56(2):e33-e35. doi: 10.1111/ijd.13430. Epub 2016 Nov 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acantholysis / chemically induced
  • Acantholysis / pathology
  • Antineoplastic Agents / adverse effects*
  • Facial Dermatoses / chemically induced
  • Facial Dermatoses / genetics
  • Facial Dermatoses / pathology
  • Female
  • Gene Expression
  • Humans
  • Indoles / adverse effects*
  • Keratoacanthoma / chemically induced*
  • Keratoacanthoma / genetics*
  • Keratoacanthoma / pathology
  • Melanoma / drug therapy*
  • Middle Aged
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics*
  • Skin Neoplasms / drug therapy*
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • ATP2A2 protein, human